Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.17 USD | +1.46% | +1.46% | -35.25% |
Financials (USD)
Sales 2024 * | 30.47M | Sales 2025 * | 71.52M | Capitalization | 1.11B |
---|---|---|---|---|---|
Net income 2024 * | -174M | Net income 2025 * | -127M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | 678M | Net cash position 2025 * | 585M | EV / Sales 2025 * | 7.32 x |
P/E ratio 2024 * |
-5.27
x | P/E ratio 2025 * |
-7.96
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | +1.46% | ||
1 week | +1.46% | ||
Current month | +13.32% | ||
1 month | -23.20% | ||
3 months | -34.64% | ||
6 months | +19.48% | ||
Current year | -35.25% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 14-08-31 |
Chief Executive Officer | 59 | 14-09-30 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 14-07-31 |
William Young
BRD | Director/Board Member | 79 | 21-11-14 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 4.17 | +1.46% | 887,252 |
24-05-08 | 4.11 | +2.49% | 1,679,145 |
24-05-07 | 4.01 | -1.72% | 2,001,208 |
24-05-06 | 4.08 | -2.63% | 2,024,007 |
24-05-03 | 4.19 | +1.95% | 1,948,998 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.25% | 1.11B | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.01% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- AUTL Stock